Position in BNTX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$16,835,256
+$5,324,143 QoQ
Shares Held
180,927
+39.7% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 282 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Amundi holds $2,427,056,148 across 70 Biotechnology names. BNTX ranks #14 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,546,509 | $768,197,412 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,013,540 | $631,982,729 | |
| 3 | RPRX |
Royalty Pharma plc
|
3,723,864 | $208,797,052 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
617,471 | $185,877,294 | |
| 5 | INCY |
Incyte Corp
|
1,181,498 | $133,934,612 | |
| 6 | TECH |
BIO-TECHNE Corp
|
1,827,241 | $129,094,576 | |
| 7 | MRNA |
Moderna, Inc.
|
888,779 | $62,241,193 | |
| 8 | ARGX |
Argenx SE
|
65,122 | $60,418,237 |
All Filings in BNTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,835,256 | 180,927 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $11,511,113 | 129,513 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $9,901,465 | 104,007 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $8,405,480 | 85,231 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $16,156,077 | 151,743 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $24,434,762 | 268,337 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $32,021,427 | 281,013 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $43,549,510 | 366,671 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $22,006,259 | 273,846 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $24,521,153 | 265,812 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $26,070,065 | 247,016 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,639,082 | 24,292 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,896,113 | 17,568 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,127,904 | 17,082 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,543,374 | 16,931 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,172,916 | 16,110 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $541,382 | 3,631 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $457,612 | 2,683 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $731,378 | 2,837 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,205,523 | 4,416 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $448,207 | 2,002 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||